Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1590/abd1806-4841.20187419 http://hdl.handle.net/11449/176483 |
Resumo: | Hypereosinophilic syndrome is defined as persistent eosinophilia (>1500/µL for more than six months) associated with organ involvement, excluding secondary causes. It is a rare, potentially lethal disease that should be considered in cutaneous conditions associated with hypereosinophilia. We report a case of erythroderma as a manifestation of hypereosinophilic syndrome. A 36-year-old male with no comorbidities presented progressive erythroderma, pruritus, peripheral neuropathy, and eosinophilia in the previous seven months. No mutations were found in FIP1L1/PDGFRA. Patient experienced rapid remission in response to oral prednisone and hydroxyurea. Cutaneous manifestations may be the only evidence of hypereosinophilic syndrome. Genotyping excludes myeloproliferative disease, thereby orienting treatment and prognosis. |
id |
UNSP_f02db4f3c3d721c84ef4239329b1689d |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/176483 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndromeDermatitisEosinophiliaExfoliativePolyneuropathiesHypereosinophilic syndrome is defined as persistent eosinophilia (>1500/µL for more than six months) associated with organ involvement, excluding secondary causes. It is a rare, potentially lethal disease that should be considered in cutaneous conditions associated with hypereosinophilia. We report a case of erythroderma as a manifestation of hypereosinophilic syndrome. A 36-year-old male with no comorbidities presented progressive erythroderma, pruritus, peripheral neuropathy, and eosinophilia in the previous seven months. No mutations were found in FIP1L1/PDGFRA. Patient experienced rapid remission in response to oral prednisone and hydroxyurea. Cutaneous manifestations may be the only evidence of hypereosinophilic syndrome. Genotyping excludes myeloproliferative disease, thereby orienting treatment and prognosis.Department of Dermatology Faculdade de Medicina de Botucatu Universidade Estadual Paulista (FMB-Unesp)Discipline of Hematology Department of Clinical Medicine Faculdade de Medicina de Botucatu Universidade Estadual Paulista (FMB-Unesp)Department of Surgery Pontifícia Universidade Católica de São Paulo (PUC-Sorocaba)Department of Dermatology Faculdade de Medicina de Botucatu Universidade Estadual Paulista (FMB-Unesp)Discipline of Hematology Department of Clinical Medicine Faculdade de Medicina de Botucatu Universidade Estadual Paulista (FMB-Unesp)Universidade Estadual Paulista (Unesp)Pontifícia Universidade Católica de São Paulo (PUC-Sorocaba)Merlotto, Maira Renata [UNESP]Cantadori, Lucas Oliveira [UNESP]Sakabe, DelmoMiot, Hélio Amante [UNESP]2018-12-11T17:20:58Z2018-12-11T17:20:58Z2018-05-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article451-453application/pdfhttp://dx.doi.org/10.1590/abd1806-4841.20187419Anais Brasileiros de Dermatologia, v. 93, n. 3, p. 451-453, 2018.1806-48410365-0596http://hdl.handle.net/11449/17648310.1590/abd1806-4841.20187419S0365-059620180003004512-s2.0-85048821475S0365-05962018000300451.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengAnais Brasileiros de Dermatologia0,520info:eu-repo/semantics/openAccess2024-01-23T07:05:47Zoai:repositorio.unesp.br:11449/176483Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-01-23T07:05:47Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
title |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
spellingShingle |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome Merlotto, Maira Renata [UNESP] Dermatitis Eosinophilia Exfoliative Polyneuropathies |
title_short |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
title_full |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
title_fullStr |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
title_full_unstemmed |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
title_sort |
Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome |
author |
Merlotto, Maira Renata [UNESP] |
author_facet |
Merlotto, Maira Renata [UNESP] Cantadori, Lucas Oliveira [UNESP] Sakabe, Delmo Miot, Hélio Amante [UNESP] |
author_role |
author |
author2 |
Cantadori, Lucas Oliveira [UNESP] Sakabe, Delmo Miot, Hélio Amante [UNESP] |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Pontifícia Universidade Católica de São Paulo (PUC-Sorocaba) |
dc.contributor.author.fl_str_mv |
Merlotto, Maira Renata [UNESP] Cantadori, Lucas Oliveira [UNESP] Sakabe, Delmo Miot, Hélio Amante [UNESP] |
dc.subject.por.fl_str_mv |
Dermatitis Eosinophilia Exfoliative Polyneuropathies |
topic |
Dermatitis Eosinophilia Exfoliative Polyneuropathies |
description |
Hypereosinophilic syndrome is defined as persistent eosinophilia (>1500/µL for more than six months) associated with organ involvement, excluding secondary causes. It is a rare, potentially lethal disease that should be considered in cutaneous conditions associated with hypereosinophilia. We report a case of erythroderma as a manifestation of hypereosinophilic syndrome. A 36-year-old male with no comorbidities presented progressive erythroderma, pruritus, peripheral neuropathy, and eosinophilia in the previous seven months. No mutations were found in FIP1L1/PDGFRA. Patient experienced rapid remission in response to oral prednisone and hydroxyurea. Cutaneous manifestations may be the only evidence of hypereosinophilic syndrome. Genotyping excludes myeloproliferative disease, thereby orienting treatment and prognosis. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-11T17:20:58Z 2018-12-11T17:20:58Z 2018-05-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/abd1806-4841.20187419 Anais Brasileiros de Dermatologia, v. 93, n. 3, p. 451-453, 2018. 1806-4841 0365-0596 http://hdl.handle.net/11449/176483 10.1590/abd1806-4841.20187419 S0365-05962018000300451 2-s2.0-85048821475 S0365-05962018000300451.pdf |
url |
http://dx.doi.org/10.1590/abd1806-4841.20187419 http://hdl.handle.net/11449/176483 |
identifier_str_mv |
Anais Brasileiros de Dermatologia, v. 93, n. 3, p. 451-453, 2018. 1806-4841 0365-0596 10.1590/abd1806-4841.20187419 S0365-05962018000300451 2-s2.0-85048821475 S0365-05962018000300451.pdf |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Anais Brasileiros de Dermatologia 0,520 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
451-453 application/pdf |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1792962410113400832 |